← Eichor
Study identifier: NCT05934682 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Latin American Surgical Outcomes Study in Pediatric Patients

Condition: Postoperative Complications · Children · Neonate  ·  Sponsor: University of Sao Paulo

PhaseN/A
Planned participants10000
Who can joinAll sexes, 1 Day to 18 Years
Healthy volunteersNo

About this study

This prospective, international, multicenter observational study will include hospitals performing pediatric surgery in participating Latin American countries. We aim to assess the incidence of hospital postoperative complications in pediatric surgical patients \< 18-years-old in Latin America. We will recruit all consecutive pediatric patients under the age of 18 years who were admitted to participating hospitals undergoing elective and nonelective surgery. The primary outcome is in-hospital postoperative complications up to 30 days after surgery.

This description comes directly from the study's public registry record.

Talk to the study team

Vinicius Quintao, MD, PhD  ·  + 55 11 2661-5795  ·  vinicius.quintao@hc.fm.usp.br

Alexandra Vieira, Pharm, MSc  ·  + 55 11 2661-5795  ·  aro@incor.usp.br

Always discuss trial participation with your own doctor first.

Locations (1)

Academic Reserach Organization, Instituto do Coracao, Hospital das Clinicas, Faculdade de Medicina, Universidade de Sao PauloSão Paulo, São Paulo, BrazilRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05934682